CACNA1C and glioblastoma: Among the known benidipine targets, mRNA encoding the L-type Ca2+ channel CACNA1C (Cav1.2) was most abundant in both glioblastoma lines strongly suggesting that the observed benidipine effects were mediated at least in part via inhibition of CACNA1C.